机构：[1]Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China四川大学华西医院[2]Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China[3]NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 117573, Singapore[4]Department of Biological Sciences, Faculty of Science, National University of Singapore, 14 Science Drive 4, Singapore 117573, Singapore[5]Department of Medical Sciences, University of Ferrara, Ferrara, Italy[6]International Joint Research Centre on Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China[7]Department of Biochemistry, Institute of Chemistry, University of S˜ao Paulo, S˜ao Paulo, Brazil[8]Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universitaet Leipzig, Leipzig, Germany[9]Mental Health Center and Psychiatric Laboratory, the State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[10]West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[11]Institute of TCM-Based Stress Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China[12]School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China[13]Acupuncture and Chronobiology Key Laboratory of Sichuan Province, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
This work was supported by the National Key Research and Development Project of China (2020YFA0509400, 2020YFC2002705, 2019YFC1709101), the NSFC (81821002, 82130082, 82341004), the Sao Paulo Research Foundation (FAPESP 2018/07366-4), the CNPq (National Council for Scientific and Technological Development, Brazil; CNPq Process 406396/2021-3), the Italian Association for Cancer Research (n. IG 13025 and IG 18581), the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (ZYYCXTD-D-202003), the Sichuan Science and Technology Program (2019YFH0108, 2022YFH0006), 1⋅3⋅5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYGD22007, ZYJC21004) and the Guangdong Basic and Applied Basic Research Foundation (2019B030302012).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|1 区医学
小类|1 区药学
最新[2023]版：
大类|1 区医学
小类|1 区药学
第一作者：
第一作者机构：[1]Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China[6]International Joint Research Centre on Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China[11]Institute of TCM-Based Stress Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China[12]School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China[13]Acupuncture and Chronobiology Key Laboratory of Sichuan Province, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
推荐引用方式(GB/T 7714)：
Jia Wenhui,Huang Zhao,Zhou Li,et al.Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies[J].Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.2023,70:100988.doi:10.1016/j.drup.2023.100988.
APA：
Jia Wenhui,Huang Zhao,Zhou Li,Liou Yih-Cherng,Di Virgilio Francesco...&Tang Yong.(2023).Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,70,
MLA：
Jia Wenhui,et al."Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies".Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 70.(2023):100988
：